ClinConnect ClinConnect Logo
Search / Trial NCT04971174

Outcomes of Periodontal Regenerative Treatment

Launched by QUEEN MARY UNIVERSITY OF LONDON · Jul 12, 2021

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This study will be divided in two parts:

Part 1: a retrospective analysis of short-term outcomes of periodontal regenerative procedures undertaken at the Barts Royal London Dental Hospital (RLDH); Part 2: a single recall visit study in which patients identified through part 1 and willing to consent for the study will be reassessed for medium-term outcomes of the regenerative procedures previously undertaken.

For part 1 historic data will be collected from available dental records at RLDH and divided in:

* Timepoint 0: the latest available full mouth periodontal assessment before surgery ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Inclusion criteria for part 1 of the study:
  • Patient age 18 and older
  • Patients that received periodontal regenerative surgical treatment at Barts RLDH from January 2017 to January 2019 with and without the use of any biomaterials, bone graft/substitute and membrane or combinations of those.
  • Available full periodontal examination records after non surgical therapy to serve as a baseline for the study and not beyond 12 months before surgery
  • Available radiographic examination of the tooth treated with surgical regenerative procedure at initial examination or after non surgical therapy to serve as a baseline for the study.
  • Additional inclusion criteria for part 2:
  • -Patient able and willing to give informed consent
  • Exclusion Criteria:
  • Exclusion criteria for part 1:
  • All the patients that do not match the inclusion criteria will be excluded from part 1.
  • Patients that received regenerative surgical treatment for the management of gingival recession.
  • Exclusion criteria for part 2:
  • Unable or unwilling to give consent
  • Pregnant women

About Queen Mary University Of London

Queen Mary University of London is a prestigious research-intensive institution recognized for its commitment to advancing medical science and improving health outcomes. As a leading sponsor of clinical trials, the university harnesses its academic excellence and innovative research capabilities to explore groundbreaking treatments and therapies across various medical disciplines. With a focus on collaboration, the institution engages with a diverse network of clinicians, researchers, and industry partners to ensure rigorous study design, ethical conduct, and the translation of research findings into clinical practice. Queen Mary University of London is dedicated to contributing to the global body of knowledge in healthcare through high-quality clinical research that prioritizes patient safety and welfare.

Locations

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Nikolaos Gkranias, PhD

Principal Investigator

Centre for Oral Clinical Research, QMUL

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials